Implantable cardioverter defibrillator having a smaller energy storage capacity

• US 5,827,326 A
• Filed: 03/29/1995
• Issued: 10/27/1998
• Est. Priority Date: 03/15/1991
• Status: Expired due to Term

• Current Assignee: Ela Medical S.A. (LivaNova Plc)
• Original Assignee: Angeion Corporation (Niterra Co., Ltd.)
• Inventors: Kroll, Mark W., Smith, Charles U., Anderson, Kenneth M., Adams, Theodore P.
• Primary Examiner(s): MANUEL, GEORGE C
• Application Number:
  US08/412,920
• Time in Patent Office: 1,308 Days
• Field of Search: 607/5, 607/34, 607/36
• US Class Current: 607/5
• CPC Class Codes: A61N 1/3758 Packaging of the components within the casing
• CPC Class Codes: A61N 1/3787 from an external energy source
• CPC Class Codes: A61N 1/3906 characterised by the form of the shockwave
• CPC Class Codes: A61N 1/3912 Output circuitry therefor, e.g. switches
• CPC Class Codes: A61N 1/3931 Protecting, e.g. back-up systems
• CPC Class Codes: A61N 1/3956 Implantable devices for applying electric shocks to the heart, e.g. for cardioversion
• CPC Class Codes: A61N 1/3975 Power supply A61N1/378 takes precedence
• CPC Class Codes: H01M 16/00 Structural combinations of different types of electrochemical generators
• CPC Class Codes: H01M 6/5016 Multimode utilisation

Abstract

A capacitor-discharge implantable cardioverter defibrillator (ICD) has a relatively smaller energy storage capacity of less than about 1.0 Amp-hours. The smaller energy storage capacity of the ICD is achieved by selecting and arranging the internal components of the ICD to deliver a maximum defibrillation countershock optimized in terms of a minimum physiologically effective current (I_pe) rather than a minimum defibrillation threshold energy (DFT). As a result of the optimization in terms of a minimum effective current I_pe, there is a significant decrease in the maximum electrical charge energy (E_c) that must be stored by the capacitor of the ICD to less than about 30 Joules, even though a higher safety margin is provided for by the device. Due to this decrease in the maximum E_c, as well as corollary decreases in the effective capacitance value required for the capacitor and the net energy storage required of the battery, the overall displacement volume of the ICD is reduced to the point where subcutaneous implantation of the device in the pectoral region of human patients is practical. The size of the capacitor is reduced because the effective capacitance required can be less than about 125 μF. By optimizing both the charging time and the countershock duration for the smaller maximum E_c, the size of the battery is reduced because the total energy storage capacity can be less than about 1.0 Amp-hours. In the preferred embodiment, the charging time for each defibrillation countershock is reduced to less than about 10 seconds and the pulse duration of the countershock is reduced to less than about 6 milliseconds.

Claims

1. An implantable cardioverter defibrillator for subcutaneous positioning within a pectoral region of a human patient comprising:

a sealed housing structure constructed of a biocompatible material;

one or more connector ports, each connector port disposed in a wall of the housing structure for providing electrical connections between an interior space of the housing structure and a corresponding electrical lead that is implanted within the human patient; and

circuitry disposed within the interior space of the housing structure and operably connected to the connector ports and responsive to a cardiac signal received from the human patient via one or more of the electrical leads to detect an arrhythmia in the cardiac signal and, in response, control delivery of one or more high energy electrical cardioversion/defibrillation countershocks of at least 0.5 joules to the human patient, the circuitry including a battery source of electrical energy having a total energy storage capacity of less than 1.0 amp-hours.

2. The implantable cardioverter defibrillator of claim 1 wherein a total weight of the implantable cardioverter defibrillator is less than about 120 grams.

3. The implantable cardioverter defibrillator of claim 1 wherein the circuitry comprises:

detection means for receiving the cardiac signal and detecting the arrhythmia;

capacitor means for storing electrical energy provided by the battery source to generate the electrical cardioversion/defibrillation countershocks; and

control means for controlling storing of the electrical energy in the capacitor means and discharging of the electric energy in the capacitor means as the one or more high energy electrical cardioversion/defibrillation countershocks.

4. The implantable cardioverter defibrillator of claim 3 wherein a maximum electrical charge energy stored by the capacitor means for each electrical cardioversion/defibrillation countershocks is less than about 30 joules.

5. The implantable cardioverter defibrillator of claim 3 wherein the battery source charges the capacitor means to the maximum electrical charge energy in less than about 10 seconds.

6. The implantable cardioverter defibrillator of claim 3 wherein the capacitor means has an effective capacitance value of less than 120 μ

F.

8. The implantable cardioverter defibrillator of claim 3 wherein the control means controls the delivery of the electrical cardioversion/defibrillation countershocks such that a pulse duration of a monophasic one of the cardioversion/defibrillation countershocks, or of a first phase of a multiphasic one of the cardioversion/defibrillation countershocks is less than about 6 milliseconds.

9. The implantable cardioverter defibrillator of claim 8 wherein the duration of each electrical cardioversion/defibrillation countershocks is determined by the control means to be the sum of:

a first value derived from a first predetermined percentage of an RC time constant, with R being a myocardial tissue resistance value and C being an effective capacitance value of the capacitor means; and

a second value derived from a second predetermined percentage of a cardioversion chronaxie, d_c, value.

10. The implantable cardioverter defibrillator of claim 9 wherein the first and second predetermined percentages are between 0.5 and 0.65.

11. The implantable cardioverter defibrillator of claim 10 wherein the first and second predetermined percentages are both 0.58.

12. The implantable cardioverter defibrillator of claim 9 wherein the first value is determined by comparing an output voltage of the electrical cardioversion/defibrillation countershock with a first predetermined percentage and the second value is determined by providing for a fixed time period equal to said second value.

13. The implantable cardioverter defibrillator of claim 12 wherein at least one of the electrical cardioversion/defibrillation countershocks is a biphasic pulse having a positive phase and negative phase.

14. The implantable cardioverter defibrillator of claim 13 wherein a duration of the positive phase and negative phase are equal and is determined by the control means to be the sum of:

a first value derived from a first predetermined percentage of an RC time constant, with R being a myocardial tissue resistance value and C being an effective capacitance value of the capacitor means; and

a second value derived from a second predetermined percentage of a cardioversion chronaxie, d_c, value.

15. The implantable defibrillator of claim 3 wherein a ratio of a physiologically effective current (I_pe) to a maximum stored energy charge (E_c) of the capacitor means is at least about 20%.

16. The implantable defibrillator of claim 1 wherein an expected useful life of the implantable defibrillator based on the energy charge storage is at least 5 years.

7. The implantable cardioverter defibrillator of claim 26 wherein the effective capacitance value of the capacitor means is an optimum capacitance value (C) determined by the simultaneous solution of the equations:

space="preserve" listing-type="equation">E.sub.c =0.5CV.sub.d.spsb.2

space="preserve" listing-type="equation">C=0.8d.sub.c /R

where E_c is said maximum charge amount, V_d is a maximum voltage for each electrical cardioversion/defibrillation countershock, d_c is a cardioversion chronaxie value and R is a myocardial tissue resistance value.